Phase I/II Trial of StemRegenin-1 Expanded Umbilical Cord Blood Hematopoietic Stem Cells Supports Testing as a Stand-Alone Graft - Wikidata - wikimedia - TriplyDB

Phase I/II Trial of StemRegenin-1 Expanded Umbilical Cord Blood Hematopoietic Stem Cells Supports Testing as a Stand-Alone Graft

Phase I/II Trial of StemRegenin-1 Expanded Umbilical Cord Blood Hematopoietic Stem Cells Supports Testing as a Stand-Alone Graft

http://www.wikidata.org/entity/Q36938847

about

Stem Cells Applications in Regenerative Medicine and Disease Therapeutics.Customizing the genome as therapy for the β-hemoglobinopathies Engineering cord blood to improve engraftment after cord blood transplant.Enhancing the efficacy of engraftment of cord blood for hematopoietic cell transplantation A breath of fresh air for umbilical cord blood.Distinct signaling programs control human hematopoietic stem cell survival and proliferation.Small-molecule phenotypic screening with stem cells.Clinical risks and healthcare utilization of haematopoietic cell transplantation for sickle cell disease in the U.S. using merged databases.Aryl hydrocarbon receptor inhibition promotes hematolymphoid development from human pluripotent stem cells.Advances in umbilical cord blood cell therapy: the present and the future.Phase II study of intrabone single unit cord blood transplantation for hematological malignancies Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies.Optimizing autologous cell grafts to improve stem cell gene therapy.Impact of Graft-Recipient ABO Compatibility on Outcomes after Umbilical Cord Blood Transplant for Nonmalignant Disease.Haematopoietic stem cell transplantation for sickle cell disease - current practice and new approaches.Individualized conditioning regimes in cord blood transplantation: Towards improved and predictable safety and efficacy.T Cell Genesis: In Vitro Veritas Est?Novel strategies for improving hematopoietic reconstruction after allogeneic hematopoietic stem cell transplantation or intensive chemotherapy.The aryl hydrocarbon receptor: a multifunctional chemical sensor for host defense and homeostatic maintenance.2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-mediated deregulation of myeloid and sebaceous gland stem/progenitor cell homeostasis.Why are hematopoietic stem cells so 'sexy'? on a search for developmental explanation.Platelet production from induced pluripotent stem cells.CRISPR/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem/Progenitor Cells Confers HIV-1 Resistance In Vivo.Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization.3D models of the hematopoietic stem cell niche under steady-state and active conditions.Immobilisation of Delta-like 1 ligand for the scalable and controlled manufacture of hematopoietic progenitor cells in a stirred bioreactor.Recombinant TAT-BMI-1 fusion protein induces ex vivo expansion of human umbilical cord blood-derived hematopoietic stem cells.A Novel High-Throughput Screening Platform Reveals an Optimized Cytokine Formulation for Human Hematopoietic Progenitor Cell Expansion.Improving Gene Therapy Efficiency through the Enrichment of Human Hematopoietic Stem Cells.Ex Vivo Selection of Transduced Hematopoietic Stem Cells for Gene Therapy of β-Hemoglobinopathies.Application of a phenotypic drug discovery strategy to identify biological and chemical starting points for inhibition of TSLP production in lung epithelial cells.Enhanced human hematopoietic stem and progenitor cell engraftment by blocking donor T cell-mediated TNFα signaling.Developments in Hematopoietic Stem Cell Expansion and Gene Editing Technologies.Dissection of Signaling Events Downstream of the c-Mpl Receptor in Murine Hematopoietic Stem Cells Via Motif-Engineered Chimeric Receptors.Transient apoptosis inhibition in donor stem cells improves hematopoietic stem cell transplantation.Ex Vivo Expansion of CD34+ CD90+ CD49f+ Hematopoietic Stem and Progenitor Cells from Non-enriched Umbilical Cord Blood with Azole Compounds.Hematopoietic Niche - Exploring Biomimetic Cues to Improve the Functionality of Hematopoietic Stem/Progenitor Cells.High-dose sitagliptin for systemic inhibition of dipeptidylpeptidase-4 to enhance engraftment of single cord umbilical cord blood transplantation.StemRegenin 1 selectively promotes expansion of Multipotent Hematopoietic Progenitors derived from Human Embryonic Stem Cells.Antagonism of PPAR-γ signaling expands human hematopoietic stem and progenitor cells by enhancing glycolysis.

P2860

Q26741792-7D2C05A6-1D86-4204-B909-53E92FA0360A Q26751061-A024EB1E-7AC2-401A-970F-4CE320343224 Q33766995-FF3626A9-FC46-4D5D-901A-D6844655C2D7 Q36984624-C2526BE8-7C32-419E-9FCC-1DE419A43131 Q37528084-18902298-5A1F-40A2-B095-6B9F55FB51D1 Q37610391-E4A53432-E666-422A-BCB9-92859376B9D7 Q38431263-9DB1C6D4-5C40-4F52-B77F-57CCCBC8FDE9 Q38619234-B9770B6B-5483-4283-B3ED-2E1B23FC879C Q38702663-CEA31258-A036-4544-94D8-1A2F3DD2EFB4 Q38734758-15459617-A131-416D-9904-B2C3D02B0B96 Q38743140-64395FE2-C522-4035-A2C0-D97FBC49BF1B Q38747929-B0E873DE-881C-4FBE-8974-6470C343DE66 Q38815488-83623784-4168-40A3-A43A-8EE9CCA5A163 Q38833975-8F48BA88-5BC4-4BF7-A48C-5721A8E94B29 Q38851953-D208D5F4-BA12-4E56-A838-EA6DD719F2FB Q38897538-3C7BE143-F185-4303-A7EC-3C5A46B91512 Q38992976-773B6262-9103-46AF-B065-6F3C6AD35D11 Q39031745-116F1B96-279A-4946-934C-3F3D189ABB3B Q39040473-7A87A9DB-E68D-4243-96A1-0A5C614E6030 Q39225721-0544C4F5-DBB3-4BBE-A5EF-3CDF86CCF407 Q39305548-6B478CC0-3847-4673-A0BE-F54F76381D05 Q40115861-FF126180-87CA-47BA-9AA0-7E999FA98DA1 Q40192805-86FFB08D-5B35-4B21-9A6E-8945601EFA61 Q40258805-908BFC66-5EAC-4830-9E69-AF7CE4446304 Q40965643-FDDBBB91-9619-4887-BAB9-3C2B674582F5 Q41263076-05D3837A-4934-4DD4-B83F-2082E0BD3891 Q41279525-59B99124-F222-47E7-A12E-8F3373A155E3 Q43258035-A8DC51F6-DBB6-4D4C-9996-2696B8E079AA Q45869288-45774BCB-F1B2-4EB7-A9E8-23F438E05D06 Q45875615-4D68631C-FA79-4723-8A9A-169F27EFA435 Q47213837-49F7D955-5FD1-47A4-8B0B-24A1DF77D513 Q47230830-9FCBDC95-9DDD-4492-B0EA-699357761A69 Q47438268-383F2F89-696E-4203-9D71-91ADFA68C967 Q47632499-26C9CEE9-3A7B-49CC-BB34-6D81878E4BF4 Q47838233-7F6C82CF-4180-4ED4-BEB4-498DFC866DBD Q48116992-E1F8C991-C29A-4143-AB17-7E586755A625 Q48589365-87AD4981-EA7C-48D9-9B46-8EC1F27405BD Q49218292-D339D269-107B-4698-93F0-D964CA3AA671 Q49387809-C6B36DDF-1617-42F7-9059-C3CD9AFD99FD Q49612432-827AF19D-8ED9-47C4-B38D-E7CCA8197023

P2860

Phase I/II Trial of StemRegenin-1 Expanded Umbilical Cord Blood Hematopoietic Stem Cells Supports Testing as a Stand-Alone Graft

http://www.wikidata.org/entity/Q36938847

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Phase I/II Trial of StemRegeni ...... Testing as a Stand-Alone Graft

@en

type

label

Phase I/II Trial of StemRegeni ...... Testing as a Stand-Alone Graft

@en

prefLabel

Phase I/II Trial of StemRegeni ...... Testing as a Stand-Alone Graft

@en

P1433

Q36938847-7B15D7E8-3F65-4D44-B01F-BB8BFB0A06F6

P1476

Q36938847-7D0C4A16-D6D6-4B1E-8D0B-B3C9CB0BDBC6

P2093

Q36938847-09051BA8-0761-4A91-B6F8-83509CC2F458

Q36938847-34B32D1C-5B61-4A07-9E23-4BE44405F6D3

Q36938847-3C902A83-801D-43E5-A115-2FBF0C81E6EC

Q36938847-42512648-AD26-49FC-8901-302844C5DC4E

Q36938847-675855D7-9DC2-4590-9C76-7EE5A0BA02C9

Q36938847-6B059FC1-0583-49BB-A323-B3AE107655E9

Q36938847-8C81476C-3315-437F-8552-2B0CD38CD389

Q36938847-BABE0839-9AF4-467C-B98C-787675C5AE30

Q36938847-D734DC19-3171-4895-834C-AC21FDE17BC0

Q36938847-FEB6F9A9-E4B4-4984-841C-5000B914EAAE

P2860

Q36938847-04E7429E-ECD4-4B24-AD88-C66073791575

Q36938847-07EFF84B-B541-400F-A105-B661E492CA8E

Q36938847-0B872DDD-45EB-4ACA-8F3C-9F78B73304CA

Q36938847-10E8BF18-4FF9-4F2D-9765-E088DA751955

Q36938847-12350690-A383-4C82-9810-28C54F497A0D

Q36938847-1FBCD13D-F7B5-458B-A2FB-5A95FE84C90D

Q36938847-30041F9C-AA73-4919-8EC1-0A48A091CC11

Q36938847-3EA2423A-14FA-47DB-879C-B977B27AABA3

Q36938847-4000FC5B-5A1A-4021-AF10-A0DC324913FF

Q36938847-41BC5AD3-FB35-4A91-B976-E579F05DEFFA

P304

Q36938847-B0D695EA-796E-4E11-8599-2CF4C3BC7F16

P31

Q36938847-E7A81D44-6028-4900-A2B0-BA5C8233B12D

P356

Q36938847-A73514F3-D0E4-41ED-BCCB-504A8564BB33

P407

Q36938847-EE87DC85-4468-405F-B011-788A0125B0BC

P433

Q36938847-A74960BC-DF95-4317-835D-326ED8A96E08

P478

Q36938847-3672E66C-2ECA-41A2-B059-9AFC9E1A7D00

P50

Q36938847-9DE739D0-7184-411A-8B29-426578E66A50

Q36938847-A624CF30-3478-4573-91E5-6953DE07B427

P577

Q36938847-EEF238D2-2F14-4ABA-B7D5-91BEBCD9351A

P698

Q36938847-C24C45F3-99B8-47E7-9347-4C00227FF020

P921

Q36938847-33911AD6-EAB8-4517-83D7-8EA0015C6B6C

Q36938847-C71E2A50-25C3-4E19-BEC6-D87E0078C3A5

P932

Q36938847-70ECB3AE-CB6C-417D-8381-A6F44C09AFE7

P356

J.STEM.2015.10.004

P1433

P1476

Phase I/II Trial of StemRegeni ...... Testing as a Stand-Alone Graft

@en

P2093

Anthony E Boitano

http://www.w3.org/2001/XMLSchema#string

Chap Le

http://www.w3.org/2001/XMLSchema#string

Claudio G Brunstein

http://www.w3.org/2001/XMLSchema#string

Conrad C Bleul

http://www.w3.org/2001/XMLSchema#string

Darin Sumstad

http://www.w3.org/2001/XMLSchema#string

David McKenna

http://www.w3.org/2001/XMLSchema#string

John E Wagner

http://www.w3.org/2001/XMLSchema#string

Julie Jones

http://www.w3.org/2001/XMLSchema#string

Michael P Cooke

http://www.w3.org/2001/XMLSchema#string

Todd E DeFor

http://www.w3.org/2001/XMLSchema#string

P2860

Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells

Advances in umbilical cord blood manipulation-from niche to bedside

DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion

Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit.

Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution.

Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment

Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution.

Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial

Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival.

Umbilical cord blood transplantation: the first 25 years and beyond.

P304

144-155

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.STEM.2015.10.004

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26669897

http://www.w3.org/2001/XMLSchema#string

P921

phase I clinical trial

phase II clinical trial

P932

4881386

http://www.w3.org/2001/XMLSchema#string